Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
13 hedge funds and large institutions have $9.72K invested in Coeptis Therapeutics Warrants in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.44% less ownership
Funds ownership: 2.5% → 2.06% (-0.44%)
54% less capital invested
Capital invested by funds: $21.4K → $9.72K (-$11.6K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$458 |
| 2 |
TSS
Two Sigma Securities
New York
|
+$302 |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$4.58K |
| 2 |
CS
Clear Street
New York
|
-$592 |
| 3 |
Walleye Trading
New York
|
-$76 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$15 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$5 |
COEPW Hedge Fund Activity: Q1 2025 in Review
13 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q1 2025, worth a combined $9.72K — down 54% from $21.4K a quarter earlier.
Fund positioning in COEPW was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Osaic Holdings, opening a new position worth an estimated $458. The largest seller was Meteora Capital, cutting an estimated $4.58K.
- 13 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $9.72K of Coeptis Therapeutics Warrants stock for Q1 2025, down 54% quarter-over-quarter.
- 2 funds opened new Coeptis Therapeutics Warrants positions in Q1 2025 and 2 closed out, a net change of 0 holders.
- The largest Coeptis Therapeutics Warrants buyer in Q1 2025 was Osaic Holdings, an estimated $458 added.
- The largest Coeptis Therapeutics Warrants seller in Q1 2025 was Meteora Capital, an estimated $4.58K sold.
Based on aggregated 13F filings for Q1 2025.